We are live on ! Find out more

500 hedge funds and large institutions have $11.5B invested in Sanofi in 2015 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 158 increasing their positions, 185 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $26.7M | Put options by funds: $11.5M

79% more funds holding in top 10

Funds holding in top 10: 1425 (+11)

1% less funds holding

Funds holding: 503500 (-3)

0.95% less ownership

Funds ownership: 19.34%18.38% (-0.95%)

3% less first-time investments, than exits

New positions opened: 37 | Existing positions closed: 38

9% less capital invested

Capital invested by funds: $12.5B → $11.5B (-$1.09B)

15% less repeat investments, than reductions

Existing positions increased: 158 | Existing positions reduced: 185

Holders
500
Holders Change
-3
Holders Change %
-0.6%
% of All Funds
13.93%
Holding in Top 10
25
Holding in Top 10 Change
+11
Holding in Top 10 Change %
+78.57%
% of All Funds
0.7%
New
37
Increased
158
Reduced
185
Closed
38
Calls
$26.7M
Puts
$11.5M
Net Calls
+$15.2M
Net Calls Change
+$1.65M

SNY Hedge Fund Activity: Q3 2015 in Review

500 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2015, worth a combined $11.5B — down 8.7% from $12.5B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of SNY and 37 opened new positions — a net loss of 1 holder — while 185 trimmed existing stakes and 158 added.

The largest buyer was Bank of America, adding an estimated $112M. The largest seller was Hotchkis & Wiley Capital Management, cutting an estimated $84.8M.

  • 500 institutional investors held Sanofi (SNY) as of Q3 2015, down from 503 in Q2 2015.
  • Funds reported $11.5B of Sanofi stock for Q3 2015, down 8.7% quarter-over-quarter.
  • 37 funds opened new Sanofi positions in Q3 2015 and 38 closed out, a net change of -1 holder.
  • The largest Sanofi buyer in Q3 2015 was Bank of America, an estimated $112M added.
  • The largest Sanofi seller in Q3 2015 was Hotchkis & Wiley Capital Management, an estimated $84.8M sold.

Based on aggregated 13F filings for Q3 2015.